
Broad-Based Technical Strength Lifts Laurus Labs Ltd to 52-Week High of Rs 1180.25
2026-05-06 11:35:27With a remarkable ascent from Rs 573.20 to Rs 1180.25 over the past year, Laurus Labs Ltd has more than doubled its share price, showcasing robust momentum that culminated in a fresh 52-week high on 6 May 2026.
Read full news article
Laurus Labs Ltd Hits All-Time High of Rs 1,186.80 as Momentum Builds Across Timeframes
2026-05-06 11:32:01Extending its remarkable rally, Laurus Labs Ltd touched a fresh all-time high of Rs 1,186.80 on 06 May 2026, continuing to outpace the broader market and its sector peers with strong momentum across multiple timeframes.
Read full news article
Broad-Based Technical Strength Lifts Laurus Labs Ltd to 52-Week High of Rs 1177.1
2026-05-05 09:48:05With a remarkable ascent from Rs 573.2 to Rs 1177.1 over the past year, Laurus Labs Ltd has nearly doubled its share price, reaching a fresh 52-week high on 5 May 2026. This milestone is underpinned by a confluence of strong technical indicators and sustained price momentum, even as the broader market trades cautiously.
Read full news article
Laurus Labs Ltd Quality Grade Downgrade: A Detailed Analysis of Business Fundamentals
2026-05-05 08:00:10Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently seen its quality grade downgraded from 'Good' to 'Average' by MarketsMOJO as of 20 April 2026. This shift reflects nuanced changes in the company’s core financial metrics, including profitability ratios, debt levels, and growth consistency. Despite a strong stock performance year-to-date, the downgrade invites a closer examination of the underlying business fundamentals to understand what has improved and what has deteriorated.
Read full news article
Laurus Labs Ltd Surges 5.11% to Day's High of Rs 1163 — Outperforms Sector by 3.9 Percentage Points
2026-05-04 10:45:59The Sensex advanced 0.93% on 4 May 2026, yet Laurus Labs Ltd outpaced the broader market with a 5.11% gain, touching an intraday high of Rs 1163. This 3.9 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific momentum rather than a market-wide lift.
Read full news article
Broad-Based Technical Strength Lifts Laurus Labs Ltd to 52-Week High of Rs 1163
2026-05-04 10:36:28With a decisive surge to Rs 1163 on 4 May 2026, Laurus Labs Ltd has reached a new 52-week high, marking an 86.11% rally from its low of Rs 573.2 over the past year. This milestone reflects a strong alignment of technical indicators and sustained price momentum, setting the stock apart in the Pharmaceuticals & Biotechnology sector.
Read full news article
Laurus Labs Ltd Reports Very Positive Quarterly Financial Performance Amid Strong Long-Term Returns
2026-05-04 08:00:10Laurus Labs Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has delivered a very positive financial performance in the quarter ended March 2026, marking a notable shift from its previously outstanding trend. The company’s latest quarterly results highlight record-breaking revenue and profitability metrics, reinforcing its mid-cap status and buoying investor confidence despite a modest day decline in share price.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
02-May-2026 | Source : BSEPlease see annexed enclosure.
Announcement under Regulation 30 (LODR)-Change in Directorate
30-Apr-2026 | Source : BSEPlease see annexed enclosure
Board Meeting Outcome for Outcome Of The Board Meeting
30-Apr-2026 | Source : BSEPlease see annexed enclosure
Corporate Actions
No Upcoming Board Meetings
Laurus Labs Ltd has declared 60% dividend, ex-date: 08 May 26
Laurus Labs Ltd has announced 2:10 stock split, ex-date: 29 Sep 20
No Bonus history available
No Rights history available








